-
1
-
-
67249091839
-
Polycystic Kidney Disease
-
Harris PC, Torres VE: Polycystic Kidney Disease. Ann Rev Med 2009;60:321-337.
-
(2009)
Ann Rev Med
, vol.60
, pp. 321-337
-
-
Harris, P.C.1
Torres, V.E.2
-
2
-
-
63849273195
-
Advances in the pathogenesis and treatment of polycystic kidney disease
-
Patel V, Chowdhury R, Igarashi P: Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens 2009;18:99-106.
-
(2009)
Curr Opin Nephrol Hypertens
, vol.18
, pp. 99-106
-
-
Patel, V.1
Chowdhury, R.2
Igarashi, P.3
-
3
-
-
67649841563
-
Autosomal dominant polycystic kidney disease: The last 3 years
-
Torres VE, Harris PC: Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009;76:149-168.
-
(2009)
Kidney Int
, vol.76
, pp. 149-168
-
-
Torres, V.E.1
Harris, P.C.2
-
4
-
-
0027240103
-
The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease
-
DOI 10.1056/NEJM199307293290503
-
Ye M, Grantham, JJ: The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:310-313. (Pubitemid 23210682)
-
(1993)
New England Journal of Medicine
, vol.329
, Issue.5
, pp. 310-313
-
-
Ye, M.1
Grantham, J.J.2
-
5
-
-
0028894081
-
In vitro fluid secretion by epithelium from polycystic kidneys
-
Grantham JJ, Ye M, Gattone VH 2nd, Sullivan LP: In vitro fluid secretion by epithelium from polycystic kidneys. J Clin Invest 1995;95:195-202.
-
(1995)
J Clin Invest
, vol.95
, pp. 195-202
-
-
Grantham, J.J.1
Ye, M.2
Sullivan, L.P.3
-
6
-
-
0029096306
-
Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells
-
Mangoo-Karim R, Ye M, Wallace DP, Grantham JJ, Sullivan LP: Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. Am J Physiol Renal Physiol 1995;269:F381-F388.
-
(1995)
Am J Physiol Renal Physiol
, vol.269
-
-
Mangoo-Karim, R.1
Ye, M.2
Wallace, D.P.3
Grantham, J.J.4
Sullivan, L.P.5
-
7
-
-
0029787141
-
The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro
-
Davidow CJ, Maser RL, Rome LA, Calvet JP, Grantham JJ: The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int 1996;50:208-218. (Pubitemid 26323715)
-
(1996)
Kidney International
, vol.50
, Issue.1
, pp. 208-218
-
-
Davidow, C.J.1
Maser, R.L.2
Rome, L.A.3
Calvet, J.P.4
Grantham, J.J.5
-
8
-
-
0030065759
-
A role for CFTR in human autosomal dominant polycystic kidney disease
-
Hanaoka K, Devuyst O, Schwiebert EM, Wilson PD, Guggino WB: A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol Cell Physiol 1996;270:C389-C399.
-
(1996)
Am J Physiol Cell Physiol
, vol.270
-
-
Hanaoka, K.1
Devuyst, O.2
Schwiebert, E.M.3
Wilson, P.D.4
Guggino, W.B.5
-
9
-
-
60549094794
-
Structural and functional analysis of liver cysts from the BALB/ccpk mouse model of PKD
-
Muchatuta M, Gattone V, Witzmann F, Blazer-Yost BL: Structural and functional analysis of liver cysts from the BALB/ccpk mouse model of PKD. Exper Biol Med 2009;234:17-27.
-
(2009)
Exper Biol Med
, vol.234
, pp. 17-27
-
-
Muchatuta, M.1
Gattone, V.2
Witzmann, F.3
Blazer-Yost, B.L.4
-
10
-
-
49149119646
-
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: Insights from the CRISP and HALT-PKD studies
-
Chapman, AR: Approaches to testing new treatments in autosomal dominant polycystic kidney disease: Insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephol 2008;3:1197-1204.
-
(2008)
Clin J Am Soc Nephol
, vol.3
, pp. 1197-1204
-
-
Chapman, A.R.1
-
11
-
-
67649873481
-
Renal injury is a third hit promoting rapid development of adult polycystic kidney disease
-
Takakura A, Contrino L, Zhou X, Bonventre JV, Sun Y, Humphreys BD, Zhou J: Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet 2009;18:2523-2531.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 2523-2531
-
-
Takakura, A.1
Contrino, L.2
Zhou, X.3
Bonventre, J.V.4
Sun, Y.5
Humphreys, B.D.6
Zhou, J.7
-
12
-
-
67649884993
-
Toxic tubular injury in kidneys from Pdk1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways
-
Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E and Peters DJM: Toxic tubular injury in kidneys from Pdk1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet 2009;18:2532-2542.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 2532-2542
-
-
Happe, H.1
Leonhard, W.N.2
Van Der Wal, A.3
Van De Water, B.4
Lantinga-Van Leeuwen, I.S.5
Breuning, M.H.6
De Heer, E.7
Peters, D.J.M.8
-
13
-
-
0034959984
-
Angiogenesis in autosomal-dominant polycystic kidney disease
-
DOI 10.1046/j.1523-1755.2001.00768.x
-
Bello-Reuss, E, Holubec K, Rajaraman S: Angiogenesis in autosomal-dominant polycystic kidney disease. Kidney Intern 2001;60:37-45. (Pubitemid 32587537)
-
(2001)
Kidney International
, vol.60
, Issue.1
, pp. 37-45
-
-
Bello-Reuss, E.1
Holubec, K.2
Rajaraman, S.3
-
14
-
-
0026786024
-
Renal histology in polycystic kidney disease with incipient and advanced renal failure
-
Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E: Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Intern 1992;42:1259-1265.
-
(1992)
Kidney Intern
, vol.42
, pp. 1259-1265
-
-
Zeier, M.1
Fehrenbach, P.2
Geberth, S.3
Mohring, K.4
Waldherr, R.5
Ritz, E.6
-
15
-
-
0034652247
-
Polycystin 1 is required for the structural integrity of blood vessels
-
DOI 10.1073/pnas.040550097
-
Kim K, Drummong I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA: Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci USA 2000;97:1731-1736. (Pubitemid 30118511)
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, Issue.4
, pp. 1731-1736
-
-
Kim, K.1
Drummond, I.2
Ibraghimov-Beskrovnaya, O.3
Klinger, K.4
Arnaout, M.A.5
-
16
-
-
0026935809
-
Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro
-
Ye, M, Grant M, Sharma M, Elzinga L, Swan S, Torres VE, Grantham JJ: Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J Am Soc Nephrol 1992; 3:984-994.
-
(1992)
J Am Soc Nephrol
, vol.3
, pp. 984-994
-
-
Ye, M.1
Grant, M.2
Sharma, M.3
Elzinga, L.4
Swan, S.5
Torres, V.E.6
Grantham, J.J.7
-
17
-
-
0028803103
-
Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease
-
Grantham JJ, Ye M, Davidow C, Holub B, Sharma M: Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995;6:1242-1249.
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 1242-1249
-
-
Grantham, J.J.1
Ye, M.2
Davidow, C.3
Holub, B.4
Sharma, M.5
-
18
-
-
33947282599
-
Identification of a forskolin-like molecule in human renal cysts
-
DOI 10.1681/ASN.2006111218
-
Putnam WC, Swenson SM, Reif GA, Wallace DB, Helmkamp GM Jr, Grantham JJ: Identification of a forskolin-like molecule in human renal cysts. J Am Soc Nephrol 2007;18:934-943. (Pubitemid 46434510)
-
(2007)
Journal of the American Society of Nephrology
, vol.18
, Issue.3
, pp. 934-943
-
-
Putnam, W.C.1
Swenson, S.M.2
Reif, G.A.3
Wallace, D.P.4
Helmkamp Jr., G.M.5
Grantham, J.J.6
-
19
-
-
0032905866
-
Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line
-
Bens M, Vallet V, Cluzeaud F, Pascual-Letallec L, Kahn A, Rafestin-Oblin, ME, Rossier BC, Vandewalle A: Corticosteroiddependent sodium transport in a novel immortalized mouse collecting duct principal cell line. J Am Soc Nephrol 1999;10:923-934. (Pubitemid 29203078)
-
(1999)
Journal of the American Society of Nephrology
, vol.10
, Issue.5
, pp. 923-934
-
-
Bens, M.1
Vallet, V.2
Cluzeaud, F.3
Pascual-Letallec, L.4
Kahn, A.5
Rafestin-Oblin, M.E.6
Rossier, B.C.7
Vandewalle, A.8
-
22
-
-
3843066593
-
Discovery of glycine hydrazide pore-occluding CFTR inhibitors: Mechanism, structure-activity analysis, and in vivo efficacy
-
DOI 10.1085/jgp.200409059
-
Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJV, Verkman AS: Discovery of glycine hydrazide poreoccluding CFTR inhibitors: Mechanism, structure-activity analysis and in vivo efficacy. J Gen Physiol 2004;124:125-137. (Pubitemid 39038187)
-
(2004)
Journal of General Physiology
, vol.124
, Issue.2
, pp. 125-137
-
-
Muanprasat, C.1
Sonawane, N.D.2
Salinas, D.3
Taddei, A.4
Galietta, L.J.V.5
Verkman, A.S.6
-
23
-
-
85171906996
-
Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, Glibenclamide, and GlyH-101
-
press
-
Stahl M, Stahl M, Brubacher MB, Forrest JN: Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, Glibenclamide, and GlyH-101. Am J Physiol Cell Physiol 2011; in press.
-
(2011)
Am J Physiol Cell Physiol
-
-
Stahl, M.1
Stahl, M.2
Brubacher, M.B.3
Forrest, J.N.4
-
24
-
-
65249119361
-
Lipid mediators in health and disease: Enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation
-
Shimizu T: Lipid mediators in health and disease: Enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol 2009;49:123-150.
-
(2009)
Annu Rev Pharmacol Toxicol
, vol.49
, pp. 123-150
-
-
Shimizu, T.1
-
25
-
-
78650141494
-
International union of basic and clinical pharmacology. LXXCIII. Lysophospholipid receptor nomenclature
-
Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH: International Union of Basic and Clinical Pharmacology. LXXCIII. Lysophospholipid receptor nomenclature. Pharm Rev 2010;62:579-587.
-
(2010)
Pharm Rev
, vol.62
, pp. 579-587
-
-
Chun, J.1
Hla, T.2
Lynch, K.R.3
Spiegel, S.4
Moolenaar, W.H.5
-
26
-
-
0041695352
-
Novel effect of N-palmitoyl-L-serine phosphoric acid on cytosolic Ca2+ levels in human osteoblasts
-
Jan CR, Lu YC, Jiann BP, Chang HT, Want JL, Chen WC, Huang JH: Novel effect of N-palmitoyl-L-serine phosphoric acid on cytosolic Ca2+ levels in human osteoblasts. Pharmacol Toxicol 2003;93:71-76.
-
(2003)
Pharmacol Toxicol
, vol.93
, pp. 71-76
-
-
Jan, C.R.1
Lu, Y.C.2
Jiann, B.P.3
Chang, H.T.4
Want, J.L.5
Chen, W.C.6
Huang, J.H.7
-
27
-
-
0031912553
-
Characterization of a receptor subtype-selective lysophosphatidic acid mimetic
-
Hooks SB, Ragan, SP, Hopper DW, Honemann CW, Durieux ME, MacDonald TL, Lynch KR: Characterization of a receptor subtype-selective lysophosphatidic acid mimetic. Mol Pharmacol 1998;53:188-194. (Pubitemid 28099727)
-
(1998)
Molecular Pharmacology
, vol.53
, Issue.2
, pp. 188-194
-
-
Hooks, S.B.1
Ragan, S.P.2
Hopper, D.W.3
Honemann, C.W.4
Durieux, M.E.5
Macdonald, T.L.6
Lynch, K.R.7
-
28
-
-
0141570981
-
Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors
-
DOI 10.1124/mol.64.4.994
-
Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, Kimura T, Tobo M, Yamazaki Y, Watanabe T, Yagi M, Sato M, Suzuki R, Murooka H, Sakai T, Nishitoba T, Im DS, Nochi H, Tamoto K, Tomura H, Fokajima F: Ki6425, a subtype-selective antagonist for EDGfamily lysophosphatidic acid receptors. Mol Pharmacol 2003;64:994-1005. (Pubitemid 37153068)
-
(2003)
Molecular Pharmacology
, vol.64
, Issue.4
, pp. 994-1005
-
-
Ohta, H.1
Sato, K.2
Murata, N.3
Damirin, A.4
Malchinkhuu, E.5
Kon, J.6
Kimura, T.7
Tobo, M.8
Yamazaki, Y.9
Watanabe, T.10
Yagi, M.11
Sato, M.12
Suzuki, R.13
Murooka, H.14
Sakai, T.15
Nishitoba, T.16
Im, D.-S.17
Nochi, H.18
Tamoto, K.19
Tomura, H.20
Okajima, F.21
more..
-
29
-
-
79953905199
-
Development of a phosphatase-resistanct, l-tyrosine derived LPA1/LPA3 dual antagonist
-
East, JE, Carter KM, Kennedy PC, Schulte NA, Toews ML, Lynch KR, MacDonald TL: Development of a phosphatase-resistanct, l-tyrosine derived LPA1/LPA3 dual antagonist. Med Chem Commun 2011;2:325-330.
-
(2011)
Med Chem Commun
, vol.2
, pp. 325-330
-
-
East, J.E.1
Carter, K.M.2
Kennedy, P.C.3
Schulte, N.A.4
Toews, M.L.5
Lynch, K.R.6
MacDonald, T.L.7
-
30
-
-
0038069067
-
Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors
-
DOI 10.1124/mol.63.5.1032
-
Virag T, Elrod DB, Liliom K, Sardar VM, Parrill AL, Kokoyama K, Durgam G, Deng W, Miller DD, Tigyi G: Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors. Mol Pharmacol 2003;63:1032-1042. (Pubitemid 36529921)
-
(2003)
Molecular Pharmacology
, vol.63
, Issue.5
, pp. 1032-1042
-
-
Virag, T.1
Elrod, D.B.2
Liliom, K.3
Sardar, V.M.4
Parrill, A.L.5
Yokoyama, K.6
Durgam, G.7
Deng, W.8
Miller, D.D.9
Tigyi, G.10
-
31
-
-
50849141709
-
Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients
-
Lai X, Bacallao RL, Blazer-Yost BL, Hong D, Mason SB, Witzmann FA: Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin Appl 2008;2:1140-1152.
-
(2008)
Proteomics Clin Appl
, vol.2
, pp. 1140-1152
-
-
Lai, X.1
Bacallao, R.L.2
Blazer-Yost, B.L.3
Hong, D.4
Mason, S.B.5
Witzmann, F.A.6
-
32
-
-
78650772659
-
Pioglitazone attenuates cystic burden in the PCK rodent model of polycystic kidney disease
-
Blazer-Yost BL, Haydon J, Eggleston-Gulyas T, Chen JH, Wang X, Gattone V, Torres VE: Pioglitazone attenuates cystic burden in the PCK rodent model of polycystic kidney disease. PPAR Res 2010;2010:274376.
-
(2010)
PPAR Res
, pp. 274376
-
-
Blazer-Yost, B.L.1
Haydon, J.2
Eggleston-Gulyas, T.3
Chen, J.H.4
Wang, X.5
Gattone, V.6
Torres, V.E.7
-
33
-
-
3843095115
-
- secretion, and renal cyst growth: A study using CFTR inhibitors
-
DOI 10.1111/j.1523-1755.2004.00967.x
-
- secretion and renal cyst growth: A study using CFTR inhibitors. Kidn Intern 2004;66:1926-1938. (Pubitemid 41094317)
-
(2004)
Kidney International
, vol.66
, Issue.5
, pp. 1926-1938
-
-
Li, H.1
Findlay, I.A.2
Sheppard, D.N.3
-
34
-
-
2442658976
-
Lysophospholipid G protein coupled receptors
-
Anliker B, Chun J: Lysophospholipid G protein coupled receptors. J Biol Chem 2004;279:20555-20558.
-
(2004)
J Biol Chem
, vol.279
, pp. 20555-20558
-
-
Anliker, B.1
Chun, J.2
-
35
-
-
33947529532
-
12/13 -mediated Rho activation
-
DOI 10.1074/jbc.M610826200
-
Lee CW, Rivera R, Dubin AE, ChunJ: LPA4/GPR23 is a Lysophosphatidic acid (LPA) receptor utilizing Gs-, Gq/Gi-mediated calcium signaling and G12/13-mediated Rho activation. J Biol Chem 2007;282:4310-4317. (Pubitemid 47100980)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.7
, pp. 4310-4317
-
-
Lee, C.-W.1
Rivera, R.2
Dubin, A.E.3
Chun, J.4
-
36
-
-
0035873561
-
Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatograph-mass spectrometry
-
Baker DL, Desiderio DM, Miller DD, Tolley B, Tigyi GJ: Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatograph-mass spectrometry. Anal Biochem 2001;292:287-295.
-
(2001)
Anal Biochem
, vol.292
, pp. 287-295
-
-
Baker, D.L.1
Desiderio, D.M.2
Miller, D.D.3
Tolley, B.4
Tigyi, G.J.5
-
37
-
-
0026795116
-
Lysophosphatidates bound to serum albumin activate membrane currents in xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells
-
Tigyi G, Miledi R: Lysophosphatidates bound to serum albumin activate membrane currents in xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. J Biol Chem 1992;267:21360-21367.
-
(1992)
J Biol Chem
, vol.267
, pp. 21360-21367
-
-
Tigyi, G.1
Miledi, R.2
-
38
-
-
0028071589
-
The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin
-
Thumser AEA, Voysey JE, Wilton DC: The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem J 1994;301:801-806. (Pubitemid 24239315)
-
(1994)
Biochemical Journal
, vol.301
, Issue.3
, pp. 801-806
-
-
Thumser, A.E.A.1
Voysey, J.E.2
Wilton, D.C.3
-
39
-
-
34247349431
-
Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin
-
DOI 10.1152/ajpcell.00510.2006
-
Osborn TM, Dahlgren C, Hartwig JH, Stossel TP: Modifications of cellular responses to lysophosphatic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 2007;292:C1323-1330. (Pubitemid 46631726)
-
(2007)
American Journal of Physiology - Cell Physiology
, vol.292
, Issue.4
-
-
Osborn, T.M.1
Dahlgren, C.2
Hartwig, J.H.3
Stossel, T.P.4
-
40
-
-
68049090011
-
Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease (ARPKD)
-
Lai X, Blazer-Yost BL, Gattone VH, Hong D, Muchatuta MN, Witzmann FA: Protein composition of liver cyst fluid from the BALB/c-cpk/+ mouse model of autosomal recessive polycystic kidney disease (ARPKD). Proteomics 2009;9:3775-3782.
-
(2009)
Proteomics
, vol.9
, pp. 3775-3782
-
-
Lai, X.1
Blazer-Yost, B.L.2
Gattone, V.H.3
Hong, D.4
Muchatuta, M.N.5
Witzmann, F.A.6
-
41
-
-
0030887477
-
Molecular basis of renal cyst formation - One hit two?
-
DOI 10.1016/S0140-6736(05)62286-6
-
Ong AC, Harris PC: Molecular basis of cyst formation -one hit or two Lancet 1997;349:1039-1040. (Pubitemid 27158244)
-
(1997)
Lancet
, vol.349
, Issue.9058
, pp. 1039-1040
-
-
Ong, A.C.M.1
Harris, P.C.2
-
42
-
-
67650661950
-
PPAR agonists inhibit vasopressin mediated anion transport in the MDCK-C7 cell line
-
Nofziger C, Brown KK, Smith CD, Harrington W, Murray D, Bisi J, Ashton TT, Maurio FP, Kalsi K, West TA, Baines D, Blazer-Yost BL: PPAR agonists inhibit vasopressin mediated anion transport in the MDCK-C7 cell line. Am J Physiol Renal Physiol 2009;297:F55-62.
-
(2009)
Am J Physiol Renal Physiol
, vol.297
-
-
Nofziger, C.1
Brown, K.K.2
Smith, C.D.3
Harrington, W.4
Murray, D.5
Bisi, J.6
Ashton, T.T.7
Maurio, F.P.8
Kalsi, K.9
West, T.A.10
Baines, D.11
Blazer-Yost, B.L.12
|